NCT04555291View on ClinicalTrials.gov

Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

October 6, 2023

Study Completion Date

October 6, 2024

Conditions
Total Hip Arthroplasty
Interventions
DRUG

Ropivacaine injection

Realization of the quadratum lumborum block type 3, ultrasounds' guided by the injection of 20 ml of ropivacaïne 2 mg/ml

OTHER

NACL

Realization of the quadratum lumborum block type 3, ultrasounds' guided by the injection of 20 ml of NACL

Trial Locations (2)

06001

CHU de nice - Anesthésie Réanimation, Nice

06700

Institut Arnaut Tzanck, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER